参考文献/References:
[1] Chambers AP,Sorrell JE,Haller A,et al.The role of pancreatic preproglucagon in glucose homeostasis in mice[J].Cell Metab,2017,25(4):927-934.e3.DOI:10.1016/j.cmet.2017.02.008.
[2] Thyssen S,Arany E,Hill DJ.Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin[J].Endocrinology,2006,147(5):2346-2356.DOI:10.1210/EN.2005-0396.
[3] Wilson ME,Kalamaras JA,German MS.Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas[J].Mech Dev,2002,115(1-2):171-176.
[4] Whalley NM,Pritchard LE,Smith DM,et al.Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?[J].J Endocrinol,2011,211(1):99-106.DOI:10.1530/JOE-11-0094.
[5] Hansen AM,Bödvarsdottir TB,Nordestgaard DN,et al.Upregulation of alpha cell glucagon-like peptide 1(GLP-1)in Psammomys obesus--an adaptive response to hyperglycaemia [J].Diabetologia,2011,54(6):1379-1387.DOI:10.1007/s00125-011-2080-1.
[6] Nie Y,Nakashima M,Brubaker PL,et al.Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats[J].J Clin Invest,2000,105(7):955-965.DOI:10.1172/JCI7456.
[7] McGirr R,Ejbick CE,Carter DE,et al.Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells[J].Endocrinology,2005,146(10):4514-4523.DOI:10.1210/EN.2005-0402.
[8] Kilimnik G,Kim A,Steiner DF,et al.Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of β-cell regeneration[J].Islets,2010,2(3):149-155.DOI:10.4161/isl.2.3.11396.
[9] Moffett RC,Vasu S,Thorens B,et al.Incretin receptor null mice reveal key role of GLP-1 but not GIP in pancreatic beta cell adaptation to pregnancy[J].PLoS One,2014,9(6):e96863.DOI:10.1371/journal.pone.0096863.
[10] Huang C,Yuan L,Cao S,et al.Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets[J].Int J Mol Med,2015,36(1):173-185.DOI:10.3892/ijmm.2015.2207.
[11] Marchetti P,Lupi R,Bugliani M,et al.A local glucagon-like peptide 1(GLP-1)system in human pancreatic islets[J].Diabetologia,2012,55(12):3262-3272.DOI:10.1007/s00125-012-2716-9.
[12] Linnemann AK,Davis DB. Glucagon-like peptide-1 and cholecystokinin production and signaling in the pancreatic islet as an adaptive response to obesity[J].J Diabetes Investig,2016,7(Suppl 1):44-49.DOI:10.1111/jdi.12465.
[13] O'Malley TJ,Fava GE,Zhang Y,et al.Progressive change of intra-islet GLP-1 production during diabetes development[J].Diabetes Metab Res Rev,2014,30(8):661-668.DOI:10.1002/dmrr.2534.
[14] Masur K,Tibaduiza EC,Chen C,et al.Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function[J].Mol Endocrinol,2005,19(5):1373-1382.DOI:10.1210/ME.2004-0350.
[15] Traub S,Meier DT,Schulze F,et al.Pancreatic α cell-derived glucagon-related peptides are required for β cell adaptation and glucose homeostasis[J].Cell Rep,2017,18(13):3192-3203.DOI:10.1016/j.celrep.2017.03.005.
[16] Vasu S,Moffett RC,Thorens B,et al.Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress[J].PLoS One,2014,9(6):e101005.DOI:10.1371/journal.pone.0101005.
[17] Lee JH,Wen X,Cho H,et al.CREB/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis[J].FASEB J,2018,32(3):1566-1578.DOI:10.1096/fj.201700845R.
[18] Sancho V,Daniele G,Lucchesi D,et al.Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line[J].PLoS One,2017,12(11):e0187836.DOI:10.1371/journal.pone.0187836.
[19] Kang ZF,Deng Y,Zhou Y,et al.Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the beta cell in mouse models of diabetes[J].Diabetologia,2013,56(2):423-433.DOI:10.1007/s00125-012-2776-x.
[20] 刘攀.胰岛素对胰岛α细胞分泌GLP-1的影响及机制[D].2016, 山东大学.
[21] Lim GE,Huang GJ,Flora N,et al.Insulin regulates glucagon-like peptide-1 secretion from the enteroendocrine L cell[J].Endocrinology,2009,150(2):580-591.DOI:10.1210/en.2008-0726.
[22] Ellingsgaard H,Hauselmann I,Schuler B,et al.Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells[J].Nat Med,2011,17(11):1481-1489.DOI:10.1038/nm.2513.
[23] Timper K,Dalmas E,Dror E,et al.Glucose-dependent insulinotropic peptide stimulates glucagon-like peptide 1 production by pancreatic islets via interleukin 6, produced by α cells[J].Gastroenterology,2016,151(1):165-179.DOI:10.1053/j.gastro.2016.03.003.
[24] Piro S,Mascali LG,Urbano F,et al.Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line(α-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells[J].PLoS One,2014,9(2):e90093.DOI:10.1371/journal.pone.0090093.
[25] Nakashima K,Shimoda M,Hamamoto S,et al.Self-inducible secretion of glucagon-like peptide-1(GLP-1)that allows MIN6 cells to maintain insulin secretion and insure cell survival[J].Mol Cell Endocrinol,2012,349(2):281-288.DOI:10.1016/j.mce.2011.11.008.
[26] Irwin N,Frizelle P,Montgomery IA,et al.Beneficial effects of the novel cholecystokinin agonist(pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes[J].Diabetologia,2012,55(10):2747-2758.DOI:10.1007/s00125-012-2654-6.
[27] Irwin N,Montgomery IA,Moffett RC,et al.Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice[J].Biochem Pharmacol,2013,85(1):81-91.DOI:10.1016/j.bcp.2012.10.008.
[28] Lavine JA,Raess PW,Stapleton DS,et al.Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival[J].Endocrinology,2010,151(8):3577-3588.DOI:10.1210/en.2010-0233.
[29] Linnemann AK,Neuman JC,Battiola TJ,et al.Glucagon-like peptide-1 regulates cholecystokinin production in β-cells to protect from apoptosis[J].Mol Endocrinol,2015,29(7):978-987.DOI:10.1210/me.2015-1030.
[30] Gu W,Winters KA,Motani AS,et al.Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor[J].Am J Physiol Endocrinol Metab,2010,299(4):E624-E632.DOI:10.1152/ajpendo.00102.2010.
[31] Ali S,Lamont BJ,Charron MJ,et al.Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis[J].J Clin Invest,2011,121(5):1917-1929.DOI:10.1172/JCI43615.
[32] Liu Z,Stanojevic V,Avadhani S,et al.Stromal cell-derived factor-1(SDF-1)/chemokine(C-X-C motif)receptor 4(CXCR4)axis activation induces intra-islet glucagon-like peptide-1(GLP-1)production and enhances beta cell survival[J].Diabetologia,2011,54(8):2067-2076.DOI:10.1007/s00125-011-2181-x.
[33] Kumar DP,Asgharpour A,Mirshahi F,et al.Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet α cells to promote glucose homeostasis[J].J Biol Chem,2016,291(13):6626-6640.DOI:10.1074/jbc.M115.699504.
[34] Kumar DP,Rajagopal S,Mahavadi S,et al.Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells[J].Biochem Biophys Res Commun,2012,427(3):600-605. DOI:10.1016/j.bbrc.2012.09.104.
相似文献/References:
[1]田甜,沈山梅.肠促胰素与骨质疏松[J].国际内分泌代谢杂志,2016,36(05):320.[doi:10.3760/cma.j.issn.1673-4157.2016.05.09]
Tian Tian,Shen Shanmei.Incretin and osteoporosis[J].International Journal of Endocrinology and Metabolism,2016,36(06):320.[doi:10.3760/cma.j.issn.1673-4157.2016.05.09]
[2]刘海逸,张欣荣,岳晓丹,等.黄连解毒汤对糖耐量减低大鼠的糖尿病
延缓作用[J].国际内分泌代谢杂志,2017,37(03):149.[doi:10.3760/cma.j.issn.1673-4157.2017.03.002]
Liu Haiyi*,Zhang Xinrong,Yue Xiaodan,et al.Effects of huang-lian-jie-du-decoction in delaying diabetes in rats with impaired glucose tolerance[J].International Journal of Endocrinology and Metabolism,2017,37(06):149.[doi:10.3760/cma.j.issn.1673-4157.2017.03.002]
[3]叶勇健 潘天荣.GLP-1受体激动剂在肥胖相关性肾病中的作用机制[J].国际内分泌代谢杂志,2019,39(01):45.[doi:10.3760/cma.j.issn.1673-4157.2019.01.011]
Ye Yongjian,Pan Tianrong.Mechanisms of GLP-1 receptor agonist in obesity-related glomerulopathy[J].International Journal of Endocrinology and Metabolism,2019,39(06):45.[doi:10.3760/cma.j.issn.1673-4157.2019.01.011]
[4]李勋 李强.长链非编码RNA影响胰岛β细胞功能的研究进展[J].国际内分泌代谢杂志,2020,40(04):233.[doi:10.3760/cma.j.issn.1673-4157.2020.04.004]
Li Xun,Li Qiang.Research progress of the effect of long non-coding RNA on the function of islet β cells[J].International Journal of Endocrinology and Metabolism,2020,40(06):233.[doi:10.3760/cma.j.issn.1673-4157.2020.04.004]
[5]李钰 孟怡媚 刘宽芝.胰高血糖素样肽-1类似物改善肌肉萎缩的研究进展[J].国际内分泌代谢杂志,2022,42(01):41.[doi:10.3760/cma.j.cn121383-20201026-10032]
Li Yu,Meng Yimei,Liu Kuanzhi..Research progress of glucagon-like peptide-1 analogues in ameliorating muscular atrophy[J].International Journal of Endocrinology and Metabolism,2022,42(06):41.[doi:10.3760/cma.j.cn121383-20201026-10032]